Peptidase sequences for human rhinovirus 61
>MER0175964 - human rhinovirus 2-type picornain 3C [C03.007] peptidase unit: 1518-1700 ( active site residue(s): 1557,1588,1664 ) (human rhinovirus 61) (Source: EMBL nucleotide FJ445144) 1 MGAQVSRQNVGTHSTQNSVSNGSSLNYFNINYFKDAASSGASKLEFSQDPSKFTDPVKDV 60 61 LEKGIPTLQSPTVEACGYSDRIIQITRGDSTITSQDVANAVVGYGVWPHYLTPQDATAID 120 121 KPSKPDTSSNRFYTLESQTWTNESKGWWWKLPDALKDMGIFGENMFYHFLGRSGYTVHVQ 180 181 CNASKFHQGTLLVAMIPEHQLATAVGGSVSAGYNYTHPGEKGRDVGKLNRESNPRQPSDD 240 241 NWLNFDGTLLGNLTIFPHQFINLRSNNSATIIVPYVNAVPMDSMLRHNNWSLVIIPICEL 300 301 RGSGVDLTIPITISISPMCAEFSGARANSQGLPVLLTPGSGQFMTTDDFQSPSALPWYHP 360 361 TKEISIPGQVRNLVELCQVDTLIPINNTEANIRNKNMYTVQLGGEPDPTTPVFTIRVDIA 420 421 SQPLATTLIGEVSSYYTHWTGSVRFSFMFCGSALTTLKLLIAYTPPGIRVPRNRKEAMLG 480 481 THLIWDVGLQSTVSMVVPWVSASHYRNTTPDTYSIAGFITCWYQTKLVVPPNTASTADML 540 541 CFVSGCKDFCLRMARDTNLHKQSGPIEQNPVERYVDEVLNEVLVVPNINQSNPTTSNSAP 600 601 VLDAAETGHTSNVQPEDMIETRYVQTSQTRDEMSVESFLGRSGCIHMSTLNINYDNYDDS 660 661 IENFKVWKINLQEMAQIRRKFELFTYARFDSEITIVPCVAGQGGDIGHVVMQYMYVPPGA 720 721 PTPEKRNDFTWQSGTNASVFWQHGQAYPRFSLPFLSIASAYYMFYDGYDGDSEITRYGTS 780 781 VTNDMGALCFRIVTEQHTNQVKITTRIYHKAKHVKVWCPRPPRAVEYTNVHLTNYKPKDS 840 841 EKQVTTFIKPRANLREIRTFGPSDMYVHVGNLIYRNLHLFNSEAHDSVLVSYSSDLVIYR 900 901 TNTVGDDFIPTCDCTQATYYCKHKNRYFPITVTSHDWYEIQESEYYPKHIQYNLLIGEGP 960 961 CEPGDCGGKLLCKHGVIGIITAGGEGHVAFIDLRHFLCAEEQGVTDYIHMLGEAFGNGFV 1020 1021 DSVKEHVNAINPVNNISKKVIKWLLRIVSAMVIIIRNSSDPQTVVATLTLIGCSGSPWRF 1080 1081 LKEKFCKWTQLTYIHKESDSWLKKFTEMCNAARGLEWIGNKISKFIEWMKSMLPQAQLKV 1140 1141 KYLNELKKLNLLEKQIENLRSADSKTQERIKVEIDTLHDLSCKFLPLYASEAKRIKVIHN 1200 1201 KCNTIIKQKKRSEPVAVMIHGSPGTGKSITTNFLARMITNESDIYSLPPDPKYFDGYDQQ 1260 1261 SVVIMDDIMQNPDGEDMALFCQMVSSVTFIPPMADLPDKGKPFDSRFVLCSTNHSMLAPP 1320 1321 TITSLQAMNRRFFLDLDIVVHDNYKDSQGKLNVSKAFKPCDVGTKIGNARCCPFICGKAV 1380 1381 TFKDRNTCLSYPLSQIYNLILQEDKRRTHVVDVMSAIFQGPISMEVPPPPAITDLLRSVK 1440 1441 TPEVIKYCEDNKWTIPADCKIERDLILANNIITIIANIISIAGIIYIIYKLFCSFQGPYS 1500 1501 GEPKPKTKIPERRVVTQGPEEEFGRSLIKHNTCVVTTDNGKFTGLGIYDKLMILPTHADP 1560 1561 GKEIYINGIATRVSDSYDMYNKQGIKLEITAVLLDRNEKFRDIRRYIPEREDDYPECNLA 1620 1621 LVANQPEPTIISVGDVISYGNILLSGNQTARMLKYNYPTKSGYCGGVLYKIGQIIGIHVG 1680 1681 GNGRDGFSAMLLRSYFSETQGEIITSKKVHECGYPTIHTPAKTKLQPSVFFDVFEGSKEP 1740 1741 AVLTEKDPRLTTDFNQALFSKYKGNVECNMSEHMKVAISHYSAQLMTLDIDPSNITLEES 1800 1801 VFGTEGLEALDLNTSAGFPYISMGIRKRDLINNSTKDITKLKVALDKYGVDLPMVTFLKD 1860 1861 ELRKKGKIMAGKTRVIEASSINDTVAFRMTYGKLFSSFHKNPGIITGSAVGCDPETFWSK 1920 1921 IPVMLDGECIMAFDYTNYDGSIHPIWFEALKQVLINLSFEHRLIDRLCKSKHIFKDTYYE 1980 1981 VEGGVPSGCSGTSIFNTMINNVIIRTLVLDAYKYIDLDKLKIIAYGDDVIFSYKYPLDME 2040 2041 AIAAEGNKYGLTITPADKSDTFKKLDYSSVTFLKRGFKQDDKYSFLIHPTFPISEIHESI 2100 2101 RWTKKPSQMQEHVLSLCHLMWHNGRDVYKEFERKIRSVSAGRALYIPPYDLLLHEWYEKF 2160 >MER0175965 - rhinovirus picornain 2A [C03.021] peptidase unit: 861-1006 ( active site residue(s): 878,895,966 ) (human rhinovirus 61) (Source: EMBL nucleotide FJ445144) 1 MGAQVSRQNVGTHSTQNSVSNGSSLNYFNINYFKDAASSGASKLEFSQDPSKFTDPVKDV 60 61 LEKGIPTLQSPTVEACGYSDRIIQITRGDSTITSQDVANAVVGYGVWPHYLTPQDATAID 120 121 KPSKPDTSSNRFYTLESQTWTNESKGWWWKLPDALKDMGIFGENMFYHFLGRSGYTVHVQ 180 181 CNASKFHQGTLLVAMIPEHQLATAVGGSVSAGYNYTHPGEKGRDVGKLNRESNPRQPSDD 240 241 NWLNFDGTLLGNLTIFPHQFINLRSNNSATIIVPYVNAVPMDSMLRHNNWSLVIIPICEL 300 301 RGSGVDLTIPITISISPMCAEFSGARANSQGLPVLLTPGSGQFMTTDDFQSPSALPWYHP 360 361 TKEISIPGQVRNLVELCQVDTLIPINNTEANIRNKNMYTVQLGGEPDPTTPVFTIRVDIA 420 421 SQPLATTLIGEVSSYYTHWTGSVRFSFMFCGSALTTLKLLIAYTPPGIRVPRNRKEAMLG 480 481 THLIWDVGLQSTVSMVVPWVSASHYRNTTPDTYSIAGFITCWYQTKLVVPPNTASTADML 540 541 CFVSGCKDFCLRMARDTNLHKQSGPIEQNPVERYVDEVLNEVLVVPNINQSNPTTSNSAP 600 601 VLDAAETGHTSNVQPEDMIETRYVQTSQTRDEMSVESFLGRSGCIHMSTLNINYDNYDDS 660 661 IENFKVWKINLQEMAQIRRKFELFTYARFDSEITIVPCVAGQGGDIGHVVMQYMYVPPGA 720 721 PTPEKRNDFTWQSGTNASVFWQHGQAYPRFSLPFLSIASAYYMFYDGYDGDSEITRYGTS 780 781 VTNDMGALCFRIVTEQHTNQVKITTRIYHKAKHVKVWCPRPPRAVEYTNVHLTNYKPKDS 840 841 EKQVTTFIKPRANLREIRTFGPSDMYVHVGNLIYRNLHLFNSEAHDSVLVSYSSDLVIYR 900 901 TNTVGDDFIPTCDCTQATYYCKHKNRYFPITVTSHDWYEIQESEYYPKHIQYNLLIGEGP 960 961 CEPGDCGGKLLCKHGVIGIITAGGEGHVAFIDLRHFLCAEEQGVTDYIHMLGEAFGNGFV 1020 1021 DSVKEHVNAINPVNNISKKVIKWLLRIVSAMVIIIRNSSDPQTVVATLTLIGCSGSPWRF 1080 1081 LKEKFCKWTQLTYIHKESDSWLKKFTEMCNAARGLEWIGNKISKFIEWMKSMLPQAQLKV 1140 1141 KYLNELKKLNLLEKQIENLRSADSKTQERIKVEIDTLHDLSCKFLPLYASEAKRIKVIHN 1200 1201 KCNTIIKQKKRSEPVAVMIHGSPGTGKSITTNFLARMITNESDIYSLPPDPKYFDGYDQQ 1260 1261 SVVIMDDIMQNPDGEDMALFCQMVSSVTFIPPMADLPDKGKPFDSRFVLCSTNHSMLAPP 1320 1321 TITSLQAMNRRFFLDLDIVVHDNYKDSQGKLNVSKAFKPCDVGTKIGNARCCPFICGKAV 1380 1381 TFKDRNTCLSYPLSQIYNLILQEDKRRTHVVDVMSAIFQGPISMEVPPPPAITDLLRSVK 1440 1441 TPEVIKYCEDNKWTIPADCKIERDLILANNIITIIANIISIAGIIYIIYKLFCSFQGPYS 1500 1501 GEPKPKTKIPERRVVTQGPEEEFGRSLIKHNTCVVTTDNGKFTGLGIYDKLMILPTHADP 1560 1561 GKEIYINGIATRVSDSYDMYNKQGIKLEITAVLLDRNEKFRDIRRYIPEREDDYPECNLA 1620 1621 LVANQPEPTIISVGDVISYGNILLSGNQTARMLKYNYPTKSGYCGGVLYKIGQIIGIHVG 1680 1681 GNGRDGFSAMLLRSYFSETQGEIITSKKVHECGYPTIHTPAKTKLQPSVFFDVFEGSKEP 1740 1741 AVLTEKDPRLTTDFNQALFSKYKGNVECNMSEHMKVAISHYSAQLMTLDIDPSNITLEES 1800 1801 VFGTEGLEALDLNTSAGFPYISMGIRKRDLINNSTKDITKLKVALDKYGVDLPMVTFLKD 1860 1861 ELRKKGKIMAGKTRVIEASSINDTVAFRMTYGKLFSSFHKNPGIITGSAVGCDPETFWSK 1920 1921 IPVMLDGECIMAFDYTNYDGSIHPIWFEALKQVLINLSFEHRLIDRLCKSKHIFKDTYYE 1980 1981 VEGGVPSGCSGTSIFNTMINNVIIRTLVLDAYKYIDLDKLKIIAYGDDVIFSYKYPLDME 2040 2041 AIAAEGNKYGLTITPADKSDTFKKLDYSSVTFLKRGFKQDDKYSFLIHPTFPISEIHESI 2100 2101 RWTKKPSQMQEHVLSLCHLMWHNGRDVYKEFERKIRSVSAGRALYIPPYDLLLHEWYEKF 2160 >MER0192951 - poliovirus capsid VP0-type self-cleaving protein [N08.001] peptidase unit: 2-335 ( active site residue(s): 69 ) (human rhinovirus 61) (Source: EMBL nucleotide FJ445144) 1 MGAQVSRQNVGTHSTQNSVSNGSSLNYFNINYFKDAASSGASKLEFSQDPSKFTDPVKDV 60 61 LEKGIPTLQSPTVEACGYSDRIIQITRGDSTITSQDVANAVVGYGVWPHYLTPQDATAID 120 121 KPSKPDTSSNRFYTLESQTWTNESKGWWWKLPDALKDMGIFGENMFYHFLGRSGYTVHVQ 180 181 CNASKFHQGTLLVAMIPEHQLATAVGGSVSAGYNYTHPGEKGRDVGKLNRESNPRQPSDD 240 241 NWLNFDGTLLGNLTIFPHQFINLRSNNSATIIVPYVNAVPMDSMLRHNNWSLVIIPICEL 300 301 RGSGVDLTIPITISISPMCAEFSGARANSQGLPVLLTPGSGQFMTTDDFQSPSALPWYHP 360 361 TKEISIPGQVRNLVELCQVDTLIPINNTEANIRNKNMYTVQLGGEPDPTTPVFTIRVDIA 420 421 SQPLATTLIGEVSSYYTHWTGSVRFSFMFCGSALTTLKLLIAYTPPGIRVPRNRKEAMLG 480 481 THLIWDVGLQSTVSMVVPWVSASHYRNTTPDTYSIAGFITCWYQTKLVVPPNTASTADML 540 541 CFVSGCKDFCLRMARDTNLHKQSGPIEQNPVERYVDEVLNEVLVVPNINQSNPTTSNSAP 600 601 VLDAAETGHTSNVQPEDMIETRYVQTSQTRDEMSVESFLGRSGCIHMSTLNINYDNYDDS 660 661 IENFKVWKINLQEMAQIRRKFELFTYARFDSEITIVPCVAGQGGDIGHVVMQYMYVPPGA 720 721 PTPEKRNDFTWQSGTNASVFWQHGQAYPRFSLPFLSIASAYYMFYDGYDGDSEITRYGTS 780 781 VTNDMGALCFRIVTEQHTNQVKITTRIYHKAKHVKVWCPRPPRAVEYTNVHLTNYKPKDS 840 841 EKQVTTFIKPRANLREIRTFGPSDMYVHVGNLIYRNLHLFNSEAHDSVLVSYSSDLVIYR 900 901 TNTVGDDFIPTCDCTQATYYCKHKNRYFPITVTSHDWYEIQESEYYPKHIQYNLLIGEGP 960 961 CEPGDCGGKLLCKHGVIGIITAGGEGHVAFIDLRHFLCAEEQGVTDYIHMLGEAFGNGFV 1020 1021 DSVKEHVNAINPVNNISKKVIKWLLRIVSAMVIIIRNSSDPQTVVATLTLIGCSGSPWRF 1080 1081 LKEKFCKWTQLTYIHKESDSWLKKFTEMCNAARGLEWIGNKISKFIEWMKSMLPQAQLKV 1140 1141 KYLNELKKLNLLEKQIENLRSADSKTQERIKVEIDTLHDLSCKFLPLYASEAKRIKVIHN 1200 1201 KCNTIIKQKKRSEPVAVMIHGSPGTGKSITTNFLARMITNESDIYSLPPDPKYFDGYDQQ 1260 1261 SVVIMDDIMQNPDGEDMALFCQMVSSVTFIPPMADLPDKGKPFDSRFVLCSTNHSMLAPP 1320 1321 TITSLQAMNRRFFLDLDIVVHDNYKDSQGKLNVSKAFKPCDVGTKIGNARCCPFICGKAV 1380 1381 TFKDRNTCLSYPLSQIYNLILQEDKRRTHVVDVMSAIFQGPISMEVPPPPAITDLLRSVK 1440 1441 TPEVIKYCEDNKWTIPADCKIERDLILANNIITIIANIISIAGIIYIIYKLFCSFQGPYS 1500 1501 GEPKPKTKIPERRVVTQGPEEEFGRSLIKHNTCVVTTDNGKFTGLGIYDKLMILPTHADP 1560 1561 GKEIYINGIATRVSDSYDMYNKQGIKLEITAVLLDRNEKFRDIRRYIPEREDDYPECNLA 1620 1621 LVANQPEPTIISVGDVISYGNILLSGNQTARMLKYNYPTKSGYCGGVLYKIGQIIGIHVG 1680 1681 GNGRDGFSAMLLRSYFSETQGEIITSKKVHECGYPTIHTPAKTKLQPSVFFDVFEGSKEP 1740 1741 AVLTEKDPRLTTDFNQALFSKYKGNVECNMSEHMKVAISHYSAQLMTLDIDPSNITLEES 1800 1801 VFGTEGLEALDLNTSAGFPYISMGIRKRDLINNSTKDITKLKVALDKYGVDLPMVTFLKD 1860 1861 ELRKKGKIMAGKTRVIEASSINDTVAFRMTYGKLFSSFHKNPGIITGSAVGCDPETFWSK 1920 1921 IPVMLDGECIMAFDYTNYDGSIHPIWFEALKQVLINLSFEHRLIDRLCKSKHIFKDTYYE 1980 1981 VEGGVPSGCSGTSIFNTMINNVIIRTLVLDAYKYIDLDKLKIIAYGDDVIFSYKYPLDME 2040 2041 AIAAEGNKYGLTITPADKSDTFKKLDYSSVTFLKRGFKQDDKYSFLIHPTFPISEIHESI 2100 2101 RWTKKPSQMQEHVLSLCHLMWHNGRDVYKEFERKIRSVSAGRALYIPPYDLLLHEWYEKF 2160
